ArticleTropical medicine and health2026
Diagnostic accuracy of ARK Checker® C/G-DyLight® 488: simultaneous detection of Giardia and Cryptosporidium by fluorescent antibody microscopy.
Article in Tropical medicine and health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
backgroundGiardiasis and cryptosporidiosis are often misdiagnosed by stool ova and parasite test (classical O&P). Multiplex PCR and rapid antigen immunochromatography (rapid-IC) could offer high diagnostic accuracy; however, their cost and restricted coverage, especially for parasites, limit routine use. This study evaluated the efficacy of adapted fluorescent antibody microscopy using ARK Checker® C/G-DyLight® 488 (FAM-TEST). The reagent is a liquid-form conjugated antibodies which directly detect Giardia cysts and Cryptosporidium oocysts under fluorescence microscopy.
methodsA total of 694 stool samples submitted for microbiological examination were screened by FAM-TEST, in which specimens were mixed with DyLight-488-labeled antibodies and examined microscopically. Samples with discordant results among these methods were additionally tested by conventional PCR with Sanger sequencing to verify infection status.
resultsDiagnostic accuracy was assessed by reference to multiplex PCR results and compared with that of rapid-IC. FAM-TEST identified Giardia and/or Cryptosporidium in 35 samples. In addition, 49 FAM-TEST-negative samples from a randomly selected month were included as negative controls. For Giardia, all FAM-TEST results were identical to those of rapid-IC, including three false negatives [88.0% sensitivity, 100% specificity, 100% positive predictive value (PPV), and 95.2% negative predictive value (NPV)]. For Cryptosporidium, FAM-TEST showed 93.8% sensitivity, 100% specificity, 100% PPV, and 98.6% NPV, which were comparable with those of rapid-IC. Notably, conventional PCR for Giardia sequences produced negative results for three samples considered to yield FAM-TEST false negatives, raising another possibility of multiplex PCR false positives or extremely low pathogen burden.
conclusionConcurrent use of FAM-TEST with classical O&P offers a cost-effective, practical diagnostic approach for enteric parasites, which especially strengthens diagnostic accuracy for giardiasis/cryptosporidiosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.